A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback